Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stem cell treatment for COVID-19
Ruonan Xu, Zhiqian Feng, Fu‐Sheng Wang
EBioMedicine (2022) Vol. 77, pp. 103920-103920
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Stem cell-based therapy for human diseases
Duc M. Hoang, Phuong T. Pham, Trung Q. Bach, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 617
Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial
Morteza Zarrabi, Mohammad Amin Shahrbaf, Masoumeh Nouri, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
Neutrophils and the Systemic Inflammatory Response Syndrome (SIRS)
Janusz Piotr Sikora, Jakub Karawani, Jarosław Sobczak
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13469-13469
Open Access | Times Cited: 30
Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19
Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 37
Mesenchymal stem/stromal cells in breast cancer development and management
Zhenbo Tu, Antoine E. Karnoub
Seminars in Cancer Biology (2022) Vol. 86, pp. 81-92
Open Access | Times Cited: 30
How I treat and prevent COVID-19 in patients with hematologic malignancies and recipients of cellular therapies
Firas El Chaer, Jeffery J. Auletta, Roy F. Chemaly
Blood (2022) Vol. 140, Iss. 7, pp. 673-684
Open Access | Times Cited: 28
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial
Tiantian Li, Bo Zhang, Hui Fang, et al.
EBioMedicine (2023) Vol. 92, pp. 104600-104600
Open Access | Times Cited: 22
Immunomodulatory approaches in managing lung inflammation in COVID‐19: A double‐edge sword
Geetika Verma, Manish Dhawan, AbdulRahman A. Saied, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 18
S-RBD-modified and miR-486-5p-engineered exosomes derived from mesenchymal stem cells suppress ferroptosis and alleviate radiation-induced lung injury and long-term pulmonary fibrosis
Weiyuan Zhang, Wen Li, Li Du, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Stem Cell Therapies for Chronic Liver Diseases: Progress and Challenges
Tiantian Li, Ze-Rui Wang, Weiqi Yao, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 9, pp. 900-911
Open Access | Times Cited: 25
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 22
COVID-19 and HSCT (Hematopoietic stem cell transplant)
Lynne Strasfeld
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101399-101399
Open Access | Times Cited: 20
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11
Mesenchymal stem cells and their derived exosomes for ALI/ARDS: A promising therapy
Dan Liang, Chang Liu, Mei Yang
Heliyon (2023) Vol. 9, Iss. 10, pp. e20387-e20387
Open Access | Times Cited: 11
Integration of human organoids single‐cell transcriptomic profiles and human genetics repurposes critical cell type‐specific drug targets for severe COVID‐19
Yunlong Ma, Yijun Zhou, Dingping Jiang, et al.
Cell Proliferation (2023) Vol. 57, Iss. 3
Open Access | Times Cited: 11
Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)
Cristina Ferreras, Clara Hernández-Blanco, Alejandro Martín‐Quirós, et al.
Cytotherapy (2023) Vol. 26, Iss. 1, pp. 25-35
Closed Access | Times Cited: 11
SARS-CoV-2 Spike Protein Induces Oxidative Stress and Senescence in Mouse and Human Lung
Joel S. Greenberger, Wen‐Chi Hou, Donna Shields, et al.
In Vivo (2024) Vol. 38, Iss. 4, pp. 1546-1556
Open Access | Times Cited: 4
The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics
Jian Tang, Yu Chen, Chunhua Wang, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Extracellular Vesicles as Drug Delivery System for Cancer Therapy
Jin Wang, Bohang Yin, Jiabing Lian, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 1029-1029
Open Access | Times Cited: 4
Viruses and neurodegeneration: a growing concern
Samia A. Shouman, Nadine Hesham, Tamer Z. Salem
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Amniotic fluid-derived mesenchymal stem cells as a therapeutic tool against cytokine storm: a comparison with umbilical cord counterparts
Salvatore Vaiasicca, David W. James, Gianmarco Melone, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
The next viral pandemic—where do we stand?
Rui Fan, Qingfen Liang, Yue Sui, et al.
Folia Microbiologica (2025)
Closed Access
Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19
Ju‐Pi Li, Kang‐Hsi Wu, Wan‐Ru Chao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8196-8196
Open Access | Times Cited: 18
Mesenchymal Stem/Stromal Cells in Organ Transplantation
Dayanand Deo, Misty Marchioni, Prakash Rao
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 791-791
Open Access | Times Cited: 15
Effectiveness and safety of normoxic allogenic umbilical cord mesenchymal stem cells administered as adjunctive treatment in patients with severe COVID-19
Bintang Soetjahjo, Rusdy Ghazali Malueka, Arief Nurudhin, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top